The main objective of VACDIVA is to solve the African swine fever (ASF) problem in Europe and affected countries, by developing three safe and effective vaccines for domestic pigs and wild boars, their companion DIVA tests and effective tools for control and eradication strategies in Europe.


Besides the commitment of the two industrial companies, VACDIVA counts with the expertise of two world ASF Reference Laboratories (WRC), the EU reference laboratory (EURL), six EU national Reference Laboratories (of 6 out of the 10 countries currently affected with ASF) and three prestigious ASF research institutions (FMV, MPG and WBVR). Dissemination, networking and training will be enlarged with the participation of pig producers (ECVC, COAG) and hunters (CIC as member of the Advisory Board).



@ASFvacdivaMay 11
Cell Lines for the Development of African Swine Fever Virus Vaccine Candidates: An Update", Our parnters from IZS h…
@ASFvacdivaFeb 22
"Afrcian Swine Fever Survey in a European Context" . This study, from @VISAVET and CISA-CSIC teams, explores risk…